Concepedia

Publication | Closed Access

LBA34 Single-agent anti-PD-1 balstilimab or in combination with anti-CTLA-4 zalifrelimab for recurrent/metastatic (R/M) cervical cancer (CC): Preliminary results of two independent phase II trials

DOI

37

Citations

0

References

2020

Year

David M. O’Malley, Ana Oaknin, Bradley J. Monk, Alexandra Léary, Frédèric Selle, Jérôme Alexandre, Leslie M. Randall, Carlos A. Rojas, Maryna Neffa, Anna Kryzhanivska,
Annals of Oncology

No additional data available for this publication yet. Check back later!